(Q34349432)

1 August 2017

1 reference

title

Cancer and the potential place for growth hormone receptor antagonist therapy (English)

1 reference

1 August 2017

K E Friend

1

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Growth Hormone & I G F Research

1 August 2017

published in

1 reference

1 August 2017

volume

11 Suppl A

1 reference

1 August 2017

page(s)

S121-3

1 reference

The Prevalence and Characteristics of Colorectal Neoplasia in Acromegaly

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

Acromegaly, colonic polyps and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

Experience with pegvisomant in the treatment of acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

1 reference

7 January 2021

Association of acromegaly and meningiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

Successful Treatment of Acromegaly: Metabolic and Clinical Studies in 145 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

Malignant intracranial neoplasms, following radiation therapy for acromegaly.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2801%2980020-4

7 January 2021

10.1016/S1096-6374(01)80020-4

Identifiers

DOI

1 reference

1 August 2017

1 reference